359 related articles for article (PubMed ID: 12764987)
41. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation.
Medina-Franco H; Abarca-Pérez L; García-Alvarez MN; Ulloa-Gómez JL; Romero-Trejo C; Sepúlveda-Méndez J
J Surg Oncol; 2008 Feb; 97(2):108-11. PubMed ID: 18181162
[TBL] [Abstract][Full Text] [Related]
42. Radio guided occult lesion localization (ROLL) for non-palpable invasive breast cancer.
Van Esser S; Hobbelink M; Van der Ploeg IM; Mali WP; Van Diest PJ; Borel Rinkes IH; Van Hillegersberg R
J Surg Oncol; 2008 Dec; 98(7):526-9. PubMed ID: 18767074
[TBL] [Abstract][Full Text] [Related]
43. Factors affecting surgical margins in nonpalpable breast tumors excised with the radioguided occult lesion localization approach.
Vernet-Tomas Mdel M; Ortega M; Vidal S; Corominas JM; Carreras R
J Obstet Gynaecol Res; 2011 May; 37(5):422-7. PubMed ID: 21272155
[TBL] [Abstract][Full Text] [Related]
44. Sentinel node occult lesion localization technique for impalpable breast cancer.
Hubley S; Barton R; Snook KL; Spillane A
ANZ J Surg; 2020 Dec; 90(12):2510-2515. PubMed ID: 33124171
[TBL] [Abstract][Full Text] [Related]
45. [US-guided localization of non-palpable breast cancer and sentinel node using 99mTechnetium-albumin colloid].
Ricart Selma V; González Noguera PJ; Camps Herrero J; Martínez Rubio C; Lloret Martí MT; Torregrosa Andrés A
Radiologia; 2007; 49(5):329-34. PubMed ID: 17910867
[TBL] [Abstract][Full Text] [Related]
46. Sentinel lymph node biopsy in the treatment of breast cancer. Experience in 527 cases.
Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; De Luca R; Irlandese E; Gili S; Lo Schiavo F
Minerva Chir; 2007 Apr; 62(2):93-9. PubMed ID: 17353851
[TBL] [Abstract][Full Text] [Related]
47. [Radioguided surgery of non-palpable breast lesions].
Armas F; Intra M; Vega V; Isla C; Hernández MJ
Rev Esp Med Nucl; 2007; 26(2):107-20; quiz 121-2. PubMed ID: 17386239
[No Abstract] [Full Text] [Related]
48. [The role of intraoperative gamma-probe-guided sentinel lymph node biopsy in the treatment of malignant melanoma and breast cancer].
Péley G; Sinkovics I; Liszkay G; Tóth J; Péter I; Farkas E; Téglás M; Hrívó A; Füzy M; Gilde K; Köves I
Orv Hetil; 1999 Oct; 140(42):2331-8. PubMed ID: 10560260
[TBL] [Abstract][Full Text] [Related]
49. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
50. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer.
Rubio IT; Diaz-Botero S; Esgueva A; Rodriguez R; Cortadellas T; Cordoba O; Espinosa-Bravo M
Eur J Surg Oncol; 2015 Jan; 41(1):46-51. PubMed ID: 25466980
[TBL] [Abstract][Full Text] [Related]
51. Radioguided excision of the nonpalpable breast cancer and simultaneous sentinel lymphnode biopsy using a single radiopharmaceutical: an original approach to accurate administration of the blue dye.
Zgajnar J; Besic N; Frković-Grazio S; Hocevar M; Vidergar B; Rener M; Lindtner J
J Surg Oncol; 2003 May; 83(1):48-50. PubMed ID: 12722097
[No Abstract] [Full Text] [Related]
52. Factors correlated to successful surgical treatment of 181 non-palpable invasive breast carcinomas.
Besic N; Kramaric A; Podnar B; Perhavec A; Music M; Grazio-Frkovic S; Zgajnar J
Breast; 2009 Oct; 18(5):294-8. PubMed ID: 19734048
[TBL] [Abstract][Full Text] [Related]
53. Radioguided occult lesion localisation in combination with detection of the sentinel lymph node in non-palpable breast cancer tumours.
Strnad P; Rob L; Halaska MG; Chod J; Zuntova A; Moravcova Z
Eur J Gynaecol Oncol; 2006; 27(3):236-8. PubMed ID: 16800248
[TBL] [Abstract][Full Text] [Related]
54. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy.
Nori J; Bazzocchi M; Boeri C; Vanzi E; Nori Bufalini F; Mangialavori G; Distante V; Masi A; Simoncini R; Londero V
Radiol Med; 2005 Apr; 109(4):330-44. PubMed ID: 15883518
[TBL] [Abstract][Full Text] [Related]
55. [Locating the sentinel node in breast cancer by gamma probe and staining agent. Preliminary study].
Vázquez Forner C; Giménez Climent J; Fliquete Peris MV; Fuster Diana C; Más Arcas C; Vázquez Albaladejo C
Rev Esp Med Nucl; 2000 Jun; 19(3):207-10. PubMed ID: 11062084
[TBL] [Abstract][Full Text] [Related]
56. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
57. [Validation protocol of sentinel node biopsy for breast cancer using radioactive tracer at the Institute of Oncology Bucharest "Prof. Dr. Alexandru Trestioreanu"].
Blidaru A; Bordea C; Voinea S; Condrea I; Albert P; Houcheimi B
Chirurgia (Bucur); 2006; 101(4):391-9. PubMed ID: 17059150
[TBL] [Abstract][Full Text] [Related]
58. Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins.
Rahusen FD; Taets van Amerongen AH; van Diest PJ; Borgstein PJ; Bleichrodt RP; Meijer S
J Surg Oncol; 1999 Oct; 72(2):72-6. PubMed ID: 10518102
[TBL] [Abstract][Full Text] [Related]
59. Sentinel node detection and radioguided occult lesion localization in breast cancer.
Trifirò G; Lavinia Travaini L; De Cicco C; Paganelli G
Phys Med; 2006; 21 Suppl 1():20-3. PubMed ID: 17645988
[TBL] [Abstract][Full Text] [Related]
60. Isotope-guided surgery for nonpalpable breast cancer.
Chow MP; Hung WK; Chu T; Lui CY; Ying M; Mak KL; Chan M
World J Surg; 2011 Jan; 35(1):165-9. PubMed ID: 20924761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
